| CRNXCrinetics Pharmaceuticals, Inc. |
US$ 7,7 mi |
-6.046,2% |
2025 |
| CRSFCrisp Momentum Inc. |
US$ 262 |
-3.086.096,9% |
2025 |
| CRTOCriteo S.A. |
US$ 1,9 bi |
7,4% |
2025 |
| CRMLCritical Metals Corp. |
n/d |
n/d |
2025 |
| CROXCrocs, Inc. |
US$ 4 bi |
-2,0% |
2025 |
| CRONCronos Group Inc. |
US$ 193,4 mi |
-4,9% |
2025 |
| CAPLCrossAmerica Partners LP |
US$ 3,7 bi |
1,1% |
2025 |
| CRWDCrowdStrike Holdings, Inc. |
US$ 4,8 bi |
-3,4% |
2026 |
| CRWECrown Equity Holdings, Inc. |
US$ 777 |
-14.602,8% |
2025 |
| CPTKWCrown PropTech Acquisitions |
n/d |
n/d |
2025 |
| CRACCrown Reserve Acquisition Corp. I |
n/d |
n/d |
n/d |
| CYRXCryoport, Inc. |
US$ 176,2 mi |
44,4% |
2025 |
| BAGZCryptex Digital Market Cap ETF |
n/d |
n/d |
n/d |
| CRCWCrypto Co |
US$ 18,5 mil |
-10.693,2% |
2025 |
| CSQRCsquare, Inc. |
n/d |
n/d |
n/d |
| CUBECubeSmart |
US$ 1,1 bi |
29,7% |
2025 |
| CUECue Biopharma, Inc. |
US$ 27,5 mi |
-96,9% |
2025 |
| CUENCuentas Inc. |
n/d |
n/d |
2025 |
| CGEMCullinan Therapeutics, Inc. |
n/d |
n/d |
2025 |
| CULLCullman Bancorp, Inc. |
n/d |
n/d |
2023 |
| CMBYCumberland Farms Ltd |
n/d |
n/d |
n/d |
| CUPRCuprina Holdings (Cayman) LTD |
US$ 38,8 mil |
-9.366,7% |
2025 |
| CURLFCuraleaf Holdings, Inc. |
US$ 1,3 bi |
-18,2% |
2025 |
| CURXCuranex Pharmaceuticals Inc |
n/d |
n/d |
2025 |
| CUBTCurative Biotechnology Inc |
n/d |
n/d |
n/d |
| CURBCurbline Properties Corp. |
US$ 182,9 mi |
21,8% |
2025 |
| CURICuriosityStream Inc. |
US$ 71,7 mi |
-9,0% |
2025 |
| CURRCurrenc Group Inc. |
US$ 37,8 mi |
-48,7% |
2025 |
| CWKCushman & Wakefield Ltd. |
US$ 10,3 bi |
0,9% |
2025 |
| CTOSCustom Truck One Source, Inc. |
US$ 1,9 bi |
-1,6% |
2025 |
| CUBICustomers Bancorp, Inc. |
n/d |
n/d |
2025 |
| CYCNCyclerion Therapeutics, Inc. |
US$ 2,1 mi |
-170,1% |
2025 |
| CYCUCycurion, Inc. |
US$ 15,1 mi |
-156,4% |
2025 |
| CYNCyngn Inc. |
US$ 219 mil |
-10.717,7% |
2025 |
| CTKBCytek Biosciences, Inc. |
US$ 201,5 mi |
-33,0% |
2025 |
| CYDYCytoDyn Inc. |
n/d |
n/d |
2026 |
| GDTCCytoMed Therapeutics Ltd |
US$ 252,3 mil |
-1.227,1% |
2025 |
| CTMXCytomX Therapeutics, Inc. |
US$ 76,2 mi |
-22,8% |
2025 |
| CTSOCytosorbents Corp |
US$ 37,1 mi |
-22,1% |
2025 |
| YCBDcbdMD, Inc. |
US$ 19,2 mi |
-10,6% |
2025 |